Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex
- 30 September 2011
- journal article
- Published by Elsevier BV in Biomaterials
- Vol. 32 (25), 5889-5899
- https://doi.org/10.1016/j.biomaterials.2011.04.079
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplexNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesiclesJournal of Controlled Release, 2009
- Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systemsBiomaterials, 2009
- Non-viral is superior to viral gene deliveryJournal of Controlled Release, 2007
- Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrierBiomaterials, 2007
- In vitro and in vivo gene-transferring characteristics of novel cationic lipids, DMKD (O,O'-dimyristyl-N-lysyl aspartate) and DMKE (O,O'-dimyristyl-N-lysyl glutamate)Journal of Controlled Release, 2006
- Preferential liver gene expression with polypropylenimine dendrimersJournal of Controlled Release, 2005
- Transfection Activity of Polyamidoamine Dendrimers Having Hydrophobic Amino Acid Residues in the PeripheryBioconjugate Chemistry, 2004
- Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginineJournal of Controlled Release, 2004
- Quantification of β-galactosidase activity after non-viral transfection in vivoJournal of Controlled Release, 2003